Top Markets
#1 Black Phoenix Black Phoenix +354.53%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.15%
#4 Akedo Akedo +52.53%
#5 Acurast Acurast +33.26%
#6 BasedHype BasedHype +27.64%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.45%
#9 Avantis Avantis +18.91%
#10 HOME HOME +14.74%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rangering i aksjer #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Aksjekurs
$0.02765
Sist synkronisert: 2024-12-23
Markedsverdi
$69.04K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Histogen Inc. (HSTO)

Kategori

Healthcare
EPS for Histogen Inc. (HSTO)
EPS per September 2023 TTM: $-3.13
Ifølge de siste økonomiske rapportene og aksjekursen til Histogen Inc. er selskapets nåværende EPS (TTM) $-3.13. Ved slutten av 2021 hadde selskapet en EPS på $-7.51, en økning sammenlignet med EPS-en i 2020 som var $-41.60.
EPS-historikk for Histogen Inc. fra 2011 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-3.13 -9.54%
2022 $-3.46 -53.93%
2021 $-7.51 -81.95%
2020 $-41.60 728.69%
2019 $-5.02 -95.77%
2018 $-118.60 -2.56%
2017 $-121.71 -53.64%
2016 $-262.55 20,096.15%
2015 $-1.30 -9.72%
2014 $-1.44 -32.08%
2013 $-2.12 -98.88%
2012 $-190.00 -26.92%
2011 $-260.00 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -653.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -986.26%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -537.70%
BE